Literature DB >> 11771685

Influence of the charge of low molecular weight proteins on their efficacy of filtration and/or adsorption on dialysis membranes with different intrinsic properties.

N Moachon1, C Boullange, S Fraud, E Vial, M Thomas, G Quash.   

Abstract

Hemodialysis membranes eliminate by filtration low-molecular-weight toxic metabolites (urea and creatinine) with minimum interactions between blood components and the membrane itself. However, the ability of a membrane to adsorb specific proteins could be beneficial if the accumulation of these same proteins is implicated in the genesis of a pathological condition. Beta-amyloidosis which accompanies the elevation of beta2-microglobulin (11.8 kDa) in the plasma of dialysed patients is one such condition (Biochem. Biophys. Res. Commun. 129 (3) (1985) 701-706: Lancet 1 (1986) 1240-1311). To determine whether increases in plasma beta2-microglobulin levels were due to differences in filtration efficacy of the membrane used and/or to certain characteristics of this protein, e.g. its charge (pI 5.7) the adsorption and filtration of [3H] beta2-microglobulin and [3H] lysozyme of similar MW 14.5 kDa, but pI: 10.8 were compared on different membranes. It was found that, neither [3H] beta2-microglobulin nor [3H] lysozyme are removed by cuprophan, whereas over 75% of beta2-microglobulin is removed by filtration on polyacrylonitrile, polyacrylonitrile-polyethyleneimine, polysulfone and >95% by adsorption to polymethylmethacrylate-BK. For lysozyme, removal by adsorption is >95% on polyacrylonitrile and polyacrylonitrile-polyethyleneimine, 72% on polymethylmethacrylate-BK and by filtration is 95% on polysulfone. Hemodialysis membranes must therefore not simply be considered as filters of low-molecular-weight metabolites but should be equally assessed for their capacity to eliminate potentially deleterious low-molecular-weight plasma proteins.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11771685     DOI: 10.1016/s0142-9612(01)00151-x

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  5 in total

1.  Adsorption of oxacalcitriol by polysulphone haemodialyser in patients with secondary hyperparathyroidism.

Authors:  Shuichi Tsuruoka; Hisashi Yamamoto; Takashi Ioka; Hitoshi Ando; Tetsuo Saito; Akio Fujimura
Journal:  Br J Clin Pharmacol       Date:  2004-11       Impact factor: 4.335

2.  Evaluation of polyethersulfone highflux hemodialysis membrane in vitro and in vivo.

Authors:  Bai-hai Su; Ping Fu; Qiu Li; Ye Tao; Zi Li; Hui-sha Zao; Chang-sheng Zhao
Journal:  J Mater Sci Mater Med       Date:  2007-07-10       Impact factor: 3.896

3.  Etanercept clearance during an in vitro model of continuous venovenous hemofiltration.

Authors:  Geoffrey M Fleming; Noha N Salama; Saada K Eid; Kenneth R Cooke; Bruce A Mueller
Journal:  Blood Purif       Date:  2009-09-01       Impact factor: 2.614

Review 4.  Treatment with echinocandins during continuous renal replacement therapy.

Authors:  Francisco González de Molina; Maria de Los Ángeles Martínez-Alberici; Ricard Ferrer
Journal:  Crit Care       Date:  2014-03-28       Impact factor: 9.097

5.  Immunomodulation using CONVEHY® for COVID-19: from the storm to the cytokine anticyclone.

Authors:  R García-Hernández; M I Espigares-López; F Miralles-Aguiar; R Gámiz-Sánchez; F J Arroyo Fernández; A Pernia Romero; L M Torres; E Calderón Seoane
Journal:  Rev Esp Anestesiol Reanim (Engl Ed)       Date:  2020-08-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.